Clinical Trial Update: A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD19 for Relapsed/Refractory CD19+ Leukemia [Phase 1, Phase 2]

View source ↗

Summary

An early-phase pediatric and young adult trial evaluating CD19-directed CAR-T cell therapy for relapsed/refractory CD19+ acute leukemia has Phase 1/Phase 2 coho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• CD19-directed CAR-T cell therapy

Snippet

Sponsor: Seattle Children's Hospital | Conditions: CD19+ Acute Leukemia | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-03-14